Uncategorized
GlaxoSmithKline to end some direct payments to health care professionals
GlaxoSmithKline announced that it will no longer pay for health care professionals to speak on the company’s behalf or to attend medical conferences, effective in 2016.The company will continue to pay for consulting, advisory and market-research services, according to a press release.